{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:12:57Z","timestamp":1791202377135,"version":"4.2.0"},"reference-count":92,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,10,15]]},"DOI":"10.18632\/oncotarget.2444","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T19:37:56Z","timestamp":1442345876000},"page":"9425-9443","source":"Crossref","is-referenced-by-count":84,"title":["Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis"],"prefix":"10.18632","volume":"5","author":[{"given":"Ryan A.","family":"Hlady","sequence":"first","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle L.","family":"Tiedemann","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA"},{"name":"Cancer Center, Georgia Regents University, Augusta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Puszyk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Zendejas","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hyeon","family":"Choi","sequence":"additional","affiliation":[{"name":"Cancer Center, Georgia Regents University, Augusta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,9,8]]},"reference":[{"issue":"2","key":"1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Forman","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"2","volume-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]","author":"Bray","year":"2013"},{"issue":"Suppl 2","key":"3","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1872-034X.2007.00168.x","article-title":"Epidemiology of hepatocellular carcinoma in USA","volume":"37","author":"El-Serag","year":"2007","journal-title":"Hepatol Res"},{"issue":"3","key":"4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","article-title":"Focus on hepatocellular carcinoma","volume":"5","author":"Llovet","year":"2004","journal-title":"Cancer Cell"},{"issue":"4","key":"5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort","volume":"41","author":"Lok","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"6","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus","volume":"36","author":"Patt","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/jhep.2002.33713","article-title":"Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?","volume":"36","author":"Perrillo","year":"2002","journal-title":"Hepatology"},{"issue":"5 Suppl 1","key":"8","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","article-title":"Hepatocellular carcinoma: recent trends in the United States","volume":"127","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"issue":"11","key":"9","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Matrisian","year":"2014","journal-title":"Cancer Res"},{"key":"10","article-title":"The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology","volume":"44","author":"Park","year":"2009","journal-title":"J Gastroenterol"},{"issue":"9","key":"11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"DePinho","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpgasthep1357","article-title":"Multimodal approaches to the treatment of hepatocellular carcinoma","volume":"6","author":"Craxi","year":"2009","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"7","key":"13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ncponc0844","article-title":"Strategies for the management of hepatocellular carcinoma","volume":"4","author":"Konstadoulakis","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"issue":"16","key":"14","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/onc.2010.36","article-title":"Viral hepatocarcinogenesis","volume":"29","author":"Chung","year":"2010","journal-title":"Oncogene"},{"issue":"5","key":"15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jhep.2013.12.014","article-title":"The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma","volume":"60","author":"Lu","year":"2014","journal-title":"J Hepatol"},{"issue":"3","key":"16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","article-title":"Viral-human chimeric transcript predisposes risk to liver cancer development and progression","volume":"25","author":"Wong","year":"2014","journal-title":"Cancer Cell"},{"issue":"7","key":"17","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"Rudolph","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.2000.0295","article-title":"Hepatitis C virus core protein promotes immortalization of primary human hepatocytes","volume":"271","author":"Ray","year":"2000","journal-title":"Virology"},{"issue":"9","key":"19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Koike","year":"1998","journal-title":"Nat Med"},{"issue":"1","key":"20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2011.06.012","article-title":"Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation","volume":"310","author":"Jang","year":"2011","journal-title":"Cancer Lett"},{"issue":"5 Suppl 1","key":"21","first-page":"S35","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Donato","year":"2004","journal-title":"Gastroenterology"},{"issue":"8","key":"22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc2191","article-title":"Molecular mechanisms of alcohol-mediated carcinogenesis","volume":"7","author":"Stickel","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1055-3207(02)00087-X","article-title":"Pathologic spectrum and prognostic significance of underlying liver disease in hepatocellular carcinoma","volume":"12","author":"Lauwers","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mrrev.2011.04.001","article-title":"Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome","volume":"727","author":"Paliwal","year":"2011","journal-title":"Mutat Res"},{"issue":"2","key":"25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.canlet.2007.11.033","article-title":"Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b","volume":"261","author":"Jang","year":"2008","journal-title":"Cancer Lett"},{"issue":"3","key":"26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1053\/jhep.2001.22507","article-title":"Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis","volume":"33","author":"Hirohashi","year":"2001","journal-title":"Hepatology"},{"issue":"11","key":"27","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/nar\/27.11.2291","article-title":"The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors","volume":"27","author":"Jones","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"28","doi-asserted-by":"crossref","first-page":"10060","DOI":"10.1073\/pnas.152121799","article-title":"Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis","volume":"99","author":"Hirohashi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2010.07.027","article-title":"Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake","volume":"54","author":"Herceg","year":"2011","journal-title":"J Hepatol"},{"issue":"11","key":"30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3748\/wjg.14.1741","article-title":"DNA methylation in hepatocellular carcinoma","volume":"14","author":"Tannapfe","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"9","key":"31","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI31457","article-title":"Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma","volume":"117","author":"Thorgeirsson","year":"2007","journal-title":"J Clin Invest"},{"issue":"5","key":"32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","article-title":"S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility","volume":"57","author":"Day","year":"2012","journal-title":"J Hepatol"},{"key":"33","article-title":"Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition","author":"Tang","year":"2013","journal-title":"Oncogene"},{"issue":"9","key":"34","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/JVI.02280-09","article-title":"Hepatitis B virus replication induces methylation of both host and viral DNA","volume":"84","author":"Torbenson","year":"2010","journal-title":"J Virol"},{"issue":"4","key":"35","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1053\/j.gastro.2007.01.034","article-title":"Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein","volume":"132","author":"Lee","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"36","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/hep.26540","article-title":"Identification of driver genes in hepatocellular carcinoma by exome sequencing","volume":"58","author":"Guindi","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gutjnl-2011-301146","article-title":"Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis","volume":"62","author":"Bataller","year":"2013","journal-title":"Gut"},{"issue":"7","key":"38","first-page":"1444","article-title":"Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells","volume":"58","author":"Lu","year":"1998","journal-title":"Cancer Res"},{"issue":"26","key":"39","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1093\/hmg\/dds394","article-title":"Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum","volume":"21","author":"Li","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"7463","key":"40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature12433","article-title":"Charting a dynamic DNA methylation landscape of the human genome","volume":"500","author":"Meissner","year":"2013","journal-title":"Nature"},{"issue":"3","key":"41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.molcel.2009.04.001","article-title":"Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary","volume":"34","author":"Emerson","year":"2009","journal-title":"Mol Cell"},{"issue":"1","key":"42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.2836","article-title":"Large conserved domains of low DNA methylation maintained by Dnmt3a","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nbt.1533","article-title":"Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells","volume":"27","author":"Church","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"7","key":"44","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","article-title":"Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs","volume":"129","author":"Chang","year":"2007","journal-title":"Cell"},{"issue":"5","key":"45","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.25870","article-title":"Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors","volume":"56","author":"Longerich","year":"2012","journal-title":"Hepatology"},{"issue":"Database issue","key":"46","first-page":"D945","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Futreal","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"47","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.085647.108","article-title":"The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions","volume":"19","author":"Malik","year":"2009","journal-title":"Genome Res"},{"issue":"6","key":"48","doi-asserted-by":"crossref","first-page":"e39603","DOI":"10.1371\/journal.pone.0039603","article-title":"Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study","volume":"7","author":"Zitzmann","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"49","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.febslet.2012.03.002","article-title":"Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease","volume":"586","author":"Ray","year":"2012","journal-title":"FEBS Lett"},{"issue":"54","key":"50","first-page":"54ra77","article-title":"An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer","volume":"2","author":"Thorgeirsson","year":"2010","journal-title":"Sci Transl Med"},{"key":"51","unstructured":"Pharmaceuticals A. 2012. SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)."},{"issue":"21","key":"52","first-page":"6039","article-title":"Reversal of drug resistance in human tumor xenografts by 2\u2032-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter","volume":"60","author":"Brown","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"53","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1074\/jbc.M111.291229","article-title":"DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression","volume":"287","author":"Zhu","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"54","doi-asserted-by":"crossref","first-page":"e84453","DOI":"10.1371\/journal.pone.0084453","article-title":"Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs","volume":"9","author":"Brieger","year":"2014","journal-title":"PLoS One"},{"issue":"20","key":"55","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.3748\/wjg.v11.i20.3020","article-title":"Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP\/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma","volume":"11","author":"Zakaria","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"4","key":"56","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2006.01.006","article-title":"Ubiquitous activation of Ras and Jak\/Stat pathways in human HCC","volume":"130","author":"Thorgeirsson","year":"2006","journal-title":"Gastroenterology"},{"issue":"8","key":"57","doi-asserted-by":"crossref","first-page":"e43593","DOI":"10.1371\/journal.pone.0043593","article-title":"Kruppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2407-11-3","article-title":"Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis","volume":"11","author":"Kobayashi","year":"2011","journal-title":"BMC Cancer"},{"issue":"9","key":"59","doi-asserted-by":"crossref","first-page":"e74625","DOI":"10.1371\/journal.pone.0074625","article-title":"Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis","volume":"8","author":"Michalopoulos","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2013.10.056","article-title":"Hepatitis virus infection affects DNA methylation in mice with humanized livers","volume":"146","author":"Zhu","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Nardi","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"5","key":"62","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Sherman","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22694","article-title":"Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients","volume":"49","author":"Di Bisceglie","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MEG.0b013e32831101b7","article-title":"Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy","volume":"21","author":"Monto","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"65","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4161\/epi.25696","article-title":"Global DNA methylation in a population with aflatoxin B 1 exposure","volume":"8","author":"Santella","year":"2013","journal-title":"Epigenetics"},{"issue":"1","key":"66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/epi.23062","article-title":"Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips","volume":"8","author":"Santella","year":"2013","journal-title":"Epigenetics"},{"key":"67","first-page":"597164","article-title":"Genome-wide and gene-specific epigenomic platforms for hepatocellular carcinoma biomarker development trials","volume":"2014","author":"Sidransky","year":"2014","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"68","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/ijc.26136","article-title":"Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma","volume":"130","author":"Neuhaus","year":"2012","journal-title":"Int J Cancer"},{"issue":"6","key":"69","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/hep.25569","article-title":"Genome-wide DNA methylation profiles in hepatocellular carcinoma","volume":"55","author":"Santella","year":"2012","journal-title":"Hepatology"},{"key":"70","first-page":"351863","article-title":"Promoter methylation of SFRP3 is frequent in hepatocellular carcinoma","volume":"2014","author":"Yan","year":"2014","journal-title":"Dis Markers"},{"key":"71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2407-10-317","article-title":"Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma","volume":"10","author":"Malfertheiner","year":"2010","journal-title":"BMC Cancer"},{"issue":"3","key":"72","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0002-9440(10)63469-4","article-title":"Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma","volume":"163","author":"Clark","year":"2003","journal-title":"Am J Pathol"},{"issue":"4","key":"73","first-page":"663","article-title":"GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas","volume":"16","author":"Nelson","year":"2000","journal-title":"Int J Oncol"},{"key":"74","first-page":"26","article-title":"Gene body methylation can alter gene expression and is a therapeutic target in cancer","author":"Liang","year":"2014","journal-title":"Cancer Cell"},{"issue":"7371","key":"75","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature10442","article-title":"CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing","volume":"479","author":"Oberdoerffer","year":"2011","journal-title":"Nature"},{"issue":"7303","key":"76","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature09165","article-title":"Conserved role of intragenic DNA methylation in regulating alternative promoters","volume":"466","author":"Heine","year":"2010","journal-title":"Nature"},{"issue":"13","key":"77","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1073\/pnas.0701059104","article-title":"Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay","volume":"104","author":"Pfeifer","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"78","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Wang","year":"2013","journal-title":"Genome Res"},{"key":"79","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"Zucman-Rossi","year":"2013","journal-title":"Nat Commun"},{"issue":"7","key":"80","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Nakano","year":"2012","journal-title":"Nat Genet"},{"issue":"9","key":"81","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ng.903","article-title":"Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma","volume":"43","author":"Papadopoulos","year":"2011","journal-title":"Nat Genet"},{"issue":"7463","key":"82","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Desmedt","year":"2013","journal-title":"Nature"},{"issue":"6","key":"83","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Letouze","year":"2012","journal-title":"Nat Genet"},{"issue":"7","key":"84","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrc3486","article-title":"Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host","volume":"13","author":"Feinberg","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"85","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1128\/MCB.00776-13","article-title":"Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas","volume":"33","author":"Opavsky","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"1","key":"86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI57292","article-title":"Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis","volume":"122","author":"Simpson","year":"2012","journal-title":"J Clin Invest"},{"key":"87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-59745-394-3_28","article-title":"Primary human hepatocyte culture for HCV study","volume":"510","author":"Liu","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"5","key":"88","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.celrep.2012.10.017","article-title":"Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells","volume":"2","author":"Robertson","year":"2012","journal-title":"Cell Rep"},{"issue":"Web Server issue","key":"89","first-page":"W170","article-title":"QUMA: quantification tool for methylation analysis","volume":"36","author":"Okano","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"90","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","article-title":"Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays","volume":"30","author":"Irizarry","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"91","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1756-8935-6-4","article-title":"Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array","volume":"6","author":"Kobor","year":"2013","journal-title":"Epigenetics Chromatin"},{"issue":"6","key":"92","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Haussler","year":"2002","journal-title":"Genome Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:35:17Z","timestamp":1691973317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,8]]},"references-count":92,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014,10,15]]}},"alternative-id":["2444","25294808"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2444","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,8]]}}}